Iridex
Company   Investors   Find a Physician   News   Careers   Germany   Search
Sales: 650.962.8100    Support: 800.388.4747
Facebook  Twitter  LinkedIn  YouTube  Instagram
  • Home
  • Products
    • Lasers
      • Cyclo G6
      • OcuLight
      • IQ 532
      • IQ 577
    • Retinal Surgical Instruments
      • Laser Probes
      • Consumables
    • Veterinary
    • Retina Delivery Devices
      • LIO
      • TxCell
    • Glaucoma Devices
      • MicroPulse P3 Device
      • Revised MicroPulse P3
      • G-Probe
      • G-Probe Illuminate
      • MicroPulse Laser Trabeculoplasty (MLT) Lens
    • ENT
    • Accessories
      • Vexio Cart
  • MicroPulse
  • PASCAL®
    • Iridex PASCAL ®
    • PASCAL® Synthesis
  • Physician Education
    • Glaucoma
      • Library
      • MicroPulse P3 - CYCLO G6
      • TSCPC G-Probe
    • Retina
      • Age-Related Macular Degeneration
      • Central Serous Chorioretinopathy
      • Diabetic Macular Edema
      • ME due to RVOs
      • ROP
      • Vitreoretinal Surgery
    • Testimonials
    • Certification
    • Webinars
    • Seminars
    • Articles
    • Manuals
  • Patient Education
    • Treat My DME
    • Treat My Glaucoma
    • Understanding ROP
    • Find A Physician
  • Contact
    • Contact Us
    • Ask A Question
    • Ask Tech Support
    • Schedule A Demo
    • Request A Quote
    • International Distributors
HOME > Physician Education > Retina > ROP ...

Physician Education

Learn How to Treat Retinopathy of Prematurity (ROP)



ME due to RVOs

 

Schedule a hands-on demo

Schedule a no-obligation demo to see for yourself how MicroPulse Technology and Iridex’s Family of Products can take YOUR practice to the next level.

Schedule a demo

Schedule a demo today!

×
  • Solutions
  • Clinical
  • ROP Technique
532 Laser

PRODUCT HIGHLIGHTS

OcuLight® SLx (Infrared 810nm Laser)

  • 810 nm laser photocoagulation is the standard of care for the treatment of ROP replacing cryotherapy and eliminating the need for infant transport out of the NICU for laser treatment
  • Reliable, high performance laser for retinal photocoagulation and glaucoma treatments, including transscleral applications
  • Wide choice of delivery systems offering a broad spectrum of treatment options
    particularly well suited for ROP
Download Brochure

 


Laser Indirect Ophthalmoscope

Laser Indirect Ophthalmoscope (LIO)

  • Facilitates treatment of ROP and peripheral retinal photocoagulation
  • Lightweight, ergonomic system; unmatched performance when combined with an Iridex laser photocoagulator
  • Optimized custom illumination optics and halogen light source provide unsurpassed viewing
Download Brochure

 


DioPexy™ Probe

LIO

Summaries of Presented & Published Articles Using LIO

Parvaresh TSRPC for ROP

Typical Laser Treatment Technique as Summarized in the Literature1

Laser treatment should be instituted within 72 hours of the diagnosis of threshold disease.

LIO
Apply laser treatment to avascular retina immediately anterior to the ridge of extraretinal fibrovascular proliferation and extending to the ora serrata for 360° in all cases. A moderately intense, gray white burn is the desired target intensity. Laser settings to achieve the desired lesion intensity vary, but often range from a power of 150 to 400 mW and duration of 0.2 to 0.3 seconds. The mean number of burns have ranged from 410 to 1556, but can vary considerably depending on the posterior extent of the ridge and the resultant spot size.

Postoperative care: Immediately after laser treatment, steroid drops or ointment may be applied. Follow-up examinations are performed weekly until the regression of plus disease and fibrovascular proliferation occurs, then every 2 to 4 weeks until 3 months of age.

If plus disease persists for 2 weeks after treatment, and there are skip areas found in the avascular periphery, additional laser should be performed to complete a near confluent pattern for 360°. If plus disease persists and a stage 4A or 4B retinal detachment develops, the authors recommend supplemental laser to skip areas to quiet the plus disease as much as possible. This precaution may decrease the risk of intra or postoperative hemorrhage when a vitrectomy is performed.



Transscleral Retinal Photocoagulation (TSRPC)
The transscleral probe is applied to the external surface of the sclera and has a diode aiming beam that allows the targeted retina to be visualized using an indirect ophthalmoscope. To achieve a grayish, white burn, typical powers are between 500 and 750 mW and a pulse duration of 2 to 3 seconds. Advantages of transscleral treatment when compared with transpupillary treatment include the reduced risk of thermal injury to the iris and lens, and the ability to treat through media opacities such as vitreous hemorrhage and miotic pupils. Disadvantages include the technical difficulty in treating zone 1 disease just anterior to the ridge without conjunctival incisions. Although the vast majority of infants can be safely treated with transpupillary laser applications, transscleral diode laser may play a role in select cases.




1Banach MJ, Bernstein DM: Laser Therapy for Retinopathy of Prematurity. Curr Opin Ophthalmol 2001;12(3):164-70.
www.ncbi.nlm.nih.gov/pubmed/11389340

Products

Lasers
Delivery Devices
Retina Consumables
Glaucoma Device

Resources

Physician Information
Patient Information
Seminars
Webinars

About Iridex

Overview
Testimonials
Iridex Cares
Newsletters
Contact Us

Company

Investors
Distributors
Careers
News
Events

twitter facebook linkedin youtuber
Copyright ©2003-2026 by Iridex Corporation
Terms of Use    Privacy Statement